Psilera Bioscience: Funding, Investors & Team (Oct 2026)
Many pharmaceutical drugs originate from nature due to intrinsic biodiversity, biological activity, and safety that has been optimized throughout time. A shift towards natural products is evident from significant interest and clinical data identifying cannabis and psychedelics as emerging therapeutics. Psilera will leverage its research strength being lead by executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of analogues based on psychoactive precursors. Lead compounds are formulated and screened against neurological targets to evaluate clinical potential with pipeline candidates in the areas of mood disorders, cognitive diseases, and addiction. Psilera’s mission is to make a significant impact on mental health and reduce human suffering.
Psilera Bioscience has raised $13.3M across 3 funding rounds on record, the most recent a Seed of $8.8M announced in May 2026.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Psilera Bioscience Company Profile and Key Stats
Latest funding round on record: May 2026.
Psilera Bioscience Funding Rounds
Psilera Bioscience raised $2.5M in a Seed announced in Jul 2021.
4.3 years later, an undisclosed round of $2.0M was announced in Oct 2025.
7 months later, a Seed of $8.8M was announced in May 2026.
Psilera Bioscience Founders and Leadership Team
Contact details for the Psilera Bioscience team: 2 of 2 have an email address on file.
Start 14-day free trial →Psilera Bioscience Funding Compared to Other Biotechnology Startups
Psilera Bioscience's latest round of $8.8M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Psilera Bioscience in Biotechnology and Tampa
Companies Similar to Psilera Bioscience
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Psilera Bioscience Funding FAQs
What does Psilera Bioscience do?
Many pharmaceutical drugs originate from nature due to intrinsic biodiversity, biological activity, and safety that has been optimized throughout time. A shift towards natural products is evident from significant interest and clinical data identifying cannabis and psychedelics as emerging therapeutics. Psilera will leverage its research strength being lead by executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of analogues based on psychoactive precursors. Lead compounds are formulated and screened against neurological targets to evaluate clinical potential with pipeline candidates in the areas of mood disorders, cognitive diseases, and addiction. Psilera’s mission is to make a significant impact on mental health and reduce human suffering.
How much funding has Psilera Bioscience raised?
Psilera Bioscience has raised $13.3M across 3 rounds on record. The most recent is a Seed of $8.8M announced in May 2026.
When did Psilera Bioscience last raise funding?
Psilera Bioscience's most recent funding round on record is a Seed of $8.8M, announced in May 2026.
Who founded Psilera Bioscience?
FundedIQ lists Jacqueline Von Salm (Founder) at Psilera Bioscience.
Who is the CEO of Psilera Bioscience?
Chris Witowski is listed as CEO at Psilera Bioscience.
Where is Psilera Bioscience headquartered?
Psilera Bioscience is based in Tampa, Florida, United States.
How many employees does Psilera Bioscience have?
Psilera Bioscience is in the 1-10 employee band.
How does Psilera Bioscience's funding compare to other Biotechnology startups?
Psilera Bioscience's latest round of $8.8M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Psilera Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Psilera Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.